Journey Medical Corp reports results for the quarter ended in December - Earnings Summary

Journey Medical

21/03/2024 21:01

* Journey Medical Corp  DERM.OQ  reported a quarterly
adjusted
loss of 12 cents​​ per share for the quarter ended in December,
higher than the same quarter last year, when the company
reported EPS of -60 cents.  The mean expectation of
three analysts for the quarter was for a loss of 8 cents per
share. Wall Street expected results to range from -9 cents to -6
cents per share.
    * Revenue fell 4.4% to $15.26 million from a year ago;
analysts
expected $15.06 million. 
    * Journey Medical Corp's reported EPS for the quarter was a
loss
of 12 cents​.
    * The company reported a quarterly loss of $2.14 million.
    * Journey Medical Corp shares had fallen by 33.3% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 9.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Journey Medical
Corp is $8.00 
This summary was machine generated from LSEG data March 21 at
09:01 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.08          -0.12          Missed
 Sep. 30 2023      -0.15          0.80           Beat
 Jun. 30 2023      -0.33          -0.29          Beat
 Mar. 31 2023      -0.45          -0.57          Missed